Goldman Sachs Upgrades BioNTech SE - Depositary Receipt () (LSE:0A3M)
Source: NASDAQ Stocks / 09 Nov 2024 06:11:54 America/New_York
Fintel reports that on November 8, 2024, Goldman Sachs upgraded their outlook for BioNTech SE - Depositary Receipt () (LSE:0A3M) from Neutral to Buy.
https://www.nasdaq.com/articles/goldman-sachs-upgrades-biontech-se-depositary-receipt-lse-0a3m